US 9181273
Morpholine-spirocyclic piperidine amides as modulators of ion channels
granted A61PA61P1/00A61P1/02
Quick answer
US patent 9181273 (Morpholine-spirocyclic piperidine amides as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16